Buy Five Prime Therapeutics Stock | FPRX Stock Price & Latest News | Public
FPRX

Five Prime Therapeutics

$0.00 (0.00%)Today
    Small Market Cap

    About FPRX

    Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on discovering and developing novel protein therapeutics. Its product candidates includes, Cabiralizumab(FPA008), Bemarituzumab(FPA144), and FPA150. The FPA008 is an antibody that inh...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.3
    -0.59
    -0.89
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.60

    Actual EPS
    Q3 2020

    Stats

    Market Cap$147,61M
    Volume14,54k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.34
    1 Year Low$1.75
    Open$3.87
    High$4.07
    Low$3.87

    Buy any stock with any amount of money.

    Download the App
    Download the app